Search

Search Constraints

You searched for: Author/Creator Falsey, Ann R

Search Results

1. 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination. (15th December 2022)

3. 2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level. (15th December 2022)

4. 330. BioFire ® FilmArray® Pneumonia Panel (PN) Results Compared to Standard Microbiologic Testing and Clinical Adjudication in Adults Hospitalized with Respiratory Illness. (15th December 2022)

5. 733. Incidence and Evaluation of the Change in Functional Status Associated with Respiratory Syncytial Virus Infection in Hospitalized Older Adults. (26th November 2018)

6. A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine. (21st December 2021)

7. Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants. (14th September 2020)

8. An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults. (23rd September 2017)

9. Association of Dynamic Changes in the CD4 T-Cell Transcriptome With Disease Severity During Primary Respiratory Syncytial Virus Infection in Young Infants. (17th August 2017)

10. Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants. (23rd December 2016)